Just 24 Weeks to Cure Hepatitis C
Using response-guided therapy, the new three drug regimen can cure Hepatitis C in just six months.
Continue reading »Using response-guided therapy, the new three drug regimen can cure Hepatitis C in just six months.
Continue reading »Upon identifying weaknesses in the Hepatitis C virus, Australian researchers believe their discovery could lead to a vaccine.
Continue reading »With the recent approval of the direct acting antivirals (DAA) Incivek and Victrelis, Hepatitis C treatment is improving. However, the next crop of DAAs has the potential to make Hepatitis C treatment even better.
Continue reading »Showing potential to be a monotherapy for chronic Hepatitis C infection, the FDA has awarded Pharmasset with fast track status for its drug in development, PSI-938.
Continue reading »For people new to treatment and those who have failed a previous treatment attempt, Vertex's Incivek can now be prescribed to Canadians with chronic Hepatitis C.
Continue reading »Hepatitis C patients in the UK can now increase their odds of beating the virus with Victrelis.
Continue reading »In animal subjects, French researchers developing a preventive Hepatitis C vaccine announced success; hopefully human trials will follow.
Continue reading »In a trial called Zenith, Vertex finds that a combination of four drugs knocked out Hepatitis C in half of participants in just 12 weeks.
Continue reading »Just like any drug, the two newly approved medications for Hepatitis C have side effects.
Continue reading »Representing the European Union's first approved Hepatitis C drug in a decade, Victrelis (boceprevir) can now be used in Europe to battle the most persistent strain of this prevalent liver virus.
Continue reading »
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window